Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Equity Average (2016 - 2025)

Historic Equity Average for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $49.4 million.

  • Xtant Medical Holdings' Equity Average rose 898.82% to $49.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.4 million, marking a year-over-year increase of 898.82%. This contributed to the annual value of $47.2 million for FY2024, which is 1028.06% up from last year.
  • According to the latest figures from Q3 2025, Xtant Medical Holdings' Equity Average is $49.4 million, which was up 898.82% from $46.2 million recorded in Q2 2025.
  • Xtant Medical Holdings' 5-year Equity Average high stood at $53.0 million for Q4 2023, and its period low was $23.9 million during Q1 2021.
  • Its 5-year average for Equity Average is $38.5 million, with a median of $33.6 million in 2021.
  • In the last 5 years, Xtant Medical Holdings' Equity Average soared by 582350.85% in 2021 and then crashed by 1635.57% in 2024.
  • Over the past 5 years, Xtant Medical Holdings' Equity Average (Quarter) stood at $31.8 million in 2021, then increased by 5.39% to $33.5 million in 2022, then skyrocketed by 58.39% to $53.0 million in 2023, then dropped by 16.36% to $44.3 million in 2024, then increased by 11.5% to $49.4 million in 2025.
  • Its last three reported values are $49.4 million in Q3 2025, $46.2 million for Q2 2025, and $43.4 million during Q1 2025.